8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: Evidence for a role of both 5-HT(1A) and dopamine D1 receptors

European Journal of Pharmacology

Volumn 314, Issue 3, 1996, Pages 285-291

  Hajós Korcsok, Éva ^a   Sharp, Trevor ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

5 HT(1A) receptor; 8 OH DPAT (8 hydroxy 2 (di N propylamino)tetralin); Dopamine D1 receptor; Microdialysis; Noradrenaline; SCH 23390

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE ANTAGONISTS; HIPPOCAMPUS; MALE; NOREPINEPHRINE; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0030608331     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00560-2     Document Type: Article

References (32)

1. Arborelius, L., G.G. Nomikos, U. Hacksell and T.H. Svensson, 1993a, (R)8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex, Acta Physiol. Scand. 148, 465.
2. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons, Naunyn-Schmiedeberg's Arch. Pharmacol. 347, 353.
3. 1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP, J. Rec. Res. 8, 107.
4. Charney, D.S., J.H. Krystal, P.L, Delgado and G.R. Heninger, 1990, Serotonin-specific drugs for anxiety and depressive disorders, Annu. Rev. Med. 41, 437.
5. Chen, N.-H. and M.E.A. Reith, 1995, Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin, J. Neurochem. 64, 1585.
6. 1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex, Brain Res. 707, 320.
7. Cowen, P.J., 1991, Serotonin receptor subtypes: implications for psychopharmacology, Br. J. Psychiatry 159 (Suppl. 12), 7.
8. 2 receptor activation decreases noradrenaline release in rat hippocampus in vivo, Br. J. Pharmacol. 107, 240.
9. 2 receptors: microdialysis studies in the awake and anaesthetised rat, Neuropharmacology 33, 411.
10. 1A receptor antagonist, Behav. Brain Res. 73, 337.
11. Fuller, R.W. and K.W. Perry, 1989, Effects of buspirone and its metabolite 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats, J. Pharmacol. Exp. Ther. 248, 50.
12. 1A receptor function in the rat in vivo, Eur. J. Pharmacol. 191, 391.
13. 2 receptors, Eur. J. Pharmacol. 154, 285.
14. 1A receptors in vivo, Proceedings of the 6th International Conference on In Vivo Methods, eds. A. Louilot, T. Durkin, U. Spampinato and M. Cador, p. 334.
15. Hicks, P.E., H. Schoemaker and S.Z. Langer, 1984, 5-HT receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain, Eur. J. Pharmacol. 105, 339.
16. 1A receptors: behavioural and in vivo brain microdialysis studies, Life Sci. 46, 955.
17. Iorio, L.C., A. Barnett, F.H. Leitz, V.P. Houser and C.A. Korduba, 1983, SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems, J. Pharmacol. Exp. Ther. 226, 462.
18. McRae-Degueurce, A., T. Dennis, L. Leger and B. Scatton, 1985, Regulation of noradrenergic neuronal activity in the rat locus coeruleus by serotoninergic afferents, Physiol. Psychol. 13, 188.
19. 1A agonists, Mol. Pharmacol. 37, 231.
20. 1A selective ligand and its effect in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam, Br. J. Pharmacol. 99, 343.
21. Muscat, R., A.M.J. Montgomery and P. Willner, 1989, Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists, Psychopharmacology 99, 402.
22. Nutt, D.J., R.B. Holman and D.N. Thomas, 1992, Noradrenergic mechanisms in anxiolytic and antidepressant drug action, in: Experimental Approaches to Anxiety and Depression, eds. J.M. Elliott, D.J. Heal and C.A. Marsden (John Wiley and Sons, Chichester) p. 101.
23. Paxinos, G. and C. Watson, 1986. The Rat Brain in Stereotaxic Coordinates (Academic Press, Sydney).
24. Pugh, M.T., K.M. O'Boyle, A.G. Molloy and J.L. Waddington, 1985, Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU 24213, Psychopharmacology 87, 308.
25. 2 antagonists, Brain Res. 385, 395.
26. Reader, T.A., R. Brière, L. Grondin and A. Ferron, 1986, Effects of p-chlorophenylalanine on cortical monoamines and on electrical activity of noradrenergic neurones, Neurochem. Res. 11, 1025.
27. Renaud, B., M. Buda, D. Lewis and J.F. Pujol, 1975, Effect of 5,6-dihydroxytryptamine on tyrosine hydroxylase activity in central catecholamine neurons of the rat, Biochem. Pharmacol. 24, 1739.
28. 1A receptor antagonist WAY100135: an in vivo microdialysis study, Eur. J. Pharmacol. 239, 195.
29. 1A autoreceptor, J. Neurosci. Meth. 34, 83.
30. 1 dopamine receptors, Neurosci. Lett. 121, 136.
31. 1A receptor activation, Br. J. Pharmacol. 115, 703.
32. 1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo, J. Pharmacol. Exp. Ther. 270, 656.